Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Omron Corp ADR (OP:OMRNY)

40.45 +2.11 (+5.50%)
Streaming Delayed Price Updated: 3:58 PM EDT, May 8, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Omron Corp ADR

News headline image
Advancing Early Detection: OMRON Healthcare Supports May Measurement Month 2026
From OMRON Healthcare
Via JCN Newswire
News headline image
OMRON Healthcare and Tricog Health strengthen collaboration in India with Tricog CardioCheck (TCC)
From OMRON Healthcare
Via JCN Newswire
News headline image
OMRON Healthcare and UCSF launch AFib trial
From OMRON Corporation
Via JCN Newswire
News headline image
OMRON Healthcare releases new Women's Heart Health Factbook
From OMRON Corporation
Via JCN Newswire
News headline image
International Women's Day: Why Menopause May Be a Missed Cardiovascular Risk Window
From OMRON Healthcare
Via JCN Newswire
News headline image
Artificial Intelligence ETFs: Have They Beaten The Market In 2024? ↗
AI ETFs like BOTZ, AIQ, and ROBO have performed well in 2024 but couldn't beat the S&P 500, driven by tech giants like NVIDIA and Microsoft. 
Via Benzinga
Topics Artificial Intelligence ETFs Stocks
News headline image
OMRNY Stock Earnings: OMRON Reported Results for Q4 2023 ↗
OMRON just reported results for the fourth quarter of 2023. 
Via InvestorPlace
News headline image
Omron's New Tech Expected To Improve Manufacturing For Samsung, Taiwan Semiconductor ↗
Omron Corp's (OTC: OMRNY) latest X-ray scanner is expected to significantly improve semiconductor manufacturing by identifying flaws at an advanced 1-nanom 
Via Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.